Panelists discuss how disease progression despite treatment in older patients with spinal muscular atrophy (SMA) may be due to natural aging effects combined with SMA, not necessarily treatment ...

Roche’s Evrysdi (risdiplam) tablets have been approved by the European Commission (EC) to treat spinal muscular atrophy (SMA) ...

Simplified storage and administration of new tablet formulation may provide greater freedom and independence for people with ...

Early intervention in Spinal Muscular Atrophy is crucial for better outcomes, emphasizing the need for timely treatment to ...

European Commission approves Roche’s Evrysdi tablet to treat spinal muscular atrophy: Basel Thursday, June 5, 2025, 09:00 Hrs [IST] Roche announced that the European Commission ...

Dr. Tejal Aslesh Tailor is an accomplished neuroscientist and molecular biologist with years of expertise in preclinical ...

Basel: Roche has announced that the European Commission (EC) has approved a label extension for Evrysdi (risdiplam) to ...

MRI imaging scans can track muscle changes in SMA children given Spinraza, a study found, with better results seen with early ...

Spinraza (nusinersen) treatment helped school-age children with SMA be more independent in tasks involving their arms and ...